Research

Life Sciences & Biotechnology

Title :

A recombinant subunit vaccine for SARS-CoV-2

Area of research :

Life Sciences & Biotechnology, Chemical Sciences, COVID-19 Research

Focus area :

COVID-19 Vaccine Development

Principal Investigator :

Prof Raghavan Varadarajan, Indian Institute of Science (IISc), Bengaluru

Timeline Start Year :

2020

Contact info :

Details

Executive Summary :

The goal is to develop a rapidly producible vaccine for protection to front-line health workers, senior citizens and individuals with co-morbidities such as cardiovascular disease and diabetes.

Total Budget (INR):

15,00,00,000

Organizations involved